As of 2026-03-31, 中国首个mRNA疫苗's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
中国首个mRNA疫苗's Mention Rate is 0.00%, lower than 0.6% of competitors
中国首个mRNA疫苗's First Mention is 0.00%, lower than 0.9% of competitors
中国首个mRNA疫苗's Preferred Rate is 0.00%, lower than 100.0% of competitors
中国首个mRNA疫苗's Positive Rate is 0.00%, lower than 8.9% of competitors
中国首个mRNA疫苗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 中中国首个mRNA疫苗 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
